Toggle menu

BRAINED

Start date:
April 2018
End date:
June 2019
Co-ordinated by:
Neurosurgery Department, Western General Hospital, Edinburgh
Main trial site:
Western General Hospital, Edinburgh

 

Blood samples will be assessed using infrared spectroscopy as part of a project looking at tumour biomarkers to ascertain whether people most at risk of having a brain tumour can be correctly identified.

This is a tissue governance project aiming to recruit 600 participants in order to inform a larger trial.

Chief Investigator

Mr Paul Brennan

Consultant Neurosurgeon

Local PI

Mr Paul Brennan

Consultant Neurosurgeon

Research Team

Rachel O'Brien

Lead Research Nurse

Sian Dalgleish

Senior Research Nurse

Clare Moceivei

Senior Research Nurse

Allan MacRaild

Stroke Lead Research Nurse

More EMERGE Trials

Assisting in identifying patients with Humeral shaft fractures in the ED by screening.

Giving patient information sheets to introduce the study, so patient has had adequate time to read and make decision about going into the trial before going to the fracture clinic.

Read more

HU-FIX

To determine the association between high-sensitivity cardiac troponin concentration and obstructive coronary artery disease in patients presenting to the Emergency Department with suspected acute coronary syndrome and cardiac troponin concentration within the normal reference range using CTCA.

Read more

PRECISE- CTCA

To determine the association between high-sensitivity cardiac troponin concentration and obstructive coronary artery disease in patients presenting to the Emergency Department with suspected acute coronary syndrome and cardiac troponin concentration within the normal reference range using CTCA.

Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2)

Read more

ATTEST2

Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2)